Botulism antitoxin heptavalent (BT-011)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Botulism antitoxin heptavalent (BT-011), covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients [Phase 4]